by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Annie De Groot | Mar 27, 2020 | News
March 26, 2020 04:42 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced it has reduced the timeline from biopsy to vaccine to under 4 weeks for its personalized neoantigen...
by Annie De Groot | Mar 5, 2019 | Events
American Association for Cancer Research (AACR) Annual MeetingFriday, March 29th – Wednesday, April 3rdGeorgia World Congress CenterAtlanta, GeorgiaThank you to everyone who attended Dr. Richard’s presentation at AACR 2019. We hope you learned something...
by Annie De Groot | Dec 3, 2017 | Thinking Out Loud -Blog
So, you say, why not? Why wait for Gritstone, BioNtec, Neon or even EpiVax Oncology when you can just DIY? If you can now sequence your own cancer mutanome (for about $5,000), and predict your own mutated epitopes using online tools, why not? Some cancer patients are...
by Annie De Groot | Dec 11, 2016 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing...